MFA Longevity Market Report
News and insights from thought leaders in the longevity economy
|
| |
Dear friends and colleagues,
As I write this, I'm about to get on a plane headed to Washington, DC for our eighth annual What's Next Longevity Innovation Summit, taking place December 15-17. I'm so pleased with the orchestra of talent at this year’s Summit, including government leaders, nonprofits, academia, key investors, and entrepreneurs who are innovating in the longevity space. Sessions and boot camps will dig into recent research and initiatives to help us more deeply understand the market and consumers shaping the longevity ecosystem - from the regulatory environment to the changing economy and momentum in the market, as well as age tech solutions and how older adults respond to them.
More than two decades of connecting leaders and innovators in the longevity space have brought us to this place, and I'm so proud of what we have been able to accomplish. We still have a few seats left, so I hope you will join us to learn, network, and maybe make some deals! Continue reading for a discount code.
Warmly,
Mary
| | | What's Next Longevity Deal Talk | | |
Episode 42: The What’s Next Longevity Innovation Summit is less than two weeks away, and it features an agenda packed with leaders, entrepreneurs, investors, and more. Our guest, CABHI Ventures Partner Mel Barsky, joins Mary Furlong, summit executive producer, and co-host Fred Fishkin to discuss who will be there and why anyone connected with the longevity economy should be there too.
See the full list of What's Next Longevity Deal Talk episodes.
| | |
Funding News
-
Voize, an AI speech companion used in nursing care, raised $50 million in Series A funding led by Balderton Capital.
-
House Rx, a healthcare technology platform focused on making specialty medications more affordable, raised $55 million in Series B equity led by New Enterprise Associates and Town Hall Ventures.
-
Cordance Medical, which uses ultrasound technology to treat brain diseases, raised $8 million in Seed funding led by Sonder Capital.
-
NextSense, creator of earbuds which monitor brain activity to help people sleep better, secured $16 million in a Series A funding round led by Ascension Ventures.
-
Reema Health, a care navigation company for complex populations, raised $19 million in a Series B round led by LRVHealth and Optum Ventures.
-
Beacon Biosignals, an AI-driven neurotechnology company known for its sleep monitoring system, secured $86 million in Series B funding backed by Innoviva, Google Ventures (GV), Nexus NeuroTech Ventures, S32, Catalio Capital Management, Takeda, General Catalyst, Logos Capital, Casdin Capital, and Indicator Ventures.
| | |
Women 50+ Critical Swing Vote
Women age 50 and over are a critical swing voting demographic. To explore their priorities and concerns, AARP launched the “She’s the Difference” research project. The latest effort in this initiative comes in the form of focus groups. Older women shared candid reflections on the state of the nation, their personal lives, and the challenges of aging. Learn more here.
| | |
Dr. Roizen Launches 4Youngevity
Dr. Michael Roizen, renowned longevity expert and former Chief Wellness Officer at Cleveland Clinic, has launched his newest venture: 4Youngevity. The company focuses on evidence-based longevity solutions designed to help individuals extend their healthspan. Dr. Roizen and the 4Youngevity team will be revealing exciting news about the company's direction and offerings at the upcoming Longevity Summit this December.
| | |
The Smarter Service Delivers 3.4x ROI
The Smarter Service published a case study of its tech concierge program at BHI Senior Living, showing a 3.4x ROI across each of the pilot communities served. 600 resident tech issues were resolved, and 20% of staff time was reclaimed. Additionally, the program showed improvements in resident satisfaction, increased usage of engagement platforms, and reduced operational strain.
| | |
Books, News, Reports, and Events
| | Please share this newsletter with colleagues who may be interested. If this newsletter was forwarded to you, subscribe here to receive it each month! | | | | |
